Syneron Medical Ltd. (NASDAQ:ELOS) shares saw an uptick in trading volume on Wednesday . 499,039 shares traded hands during mid-day trading, an increase of 151% from the previous session’s volume of 198,756 shares.The stock last traded at $6.56 and had previously closed at $6.76.

A number of brokerages recently issued reports on ELOS. Brean Capital reissued a “buy” rating and issued a $13.00 target price on shares of Syneron Medical in a research report on Monday, August 8th. Leerink Swann cut Syneron Medical from an “outperform” rating to a “market perform” rating and decreased their target price for the company from $9.40 to $7.80 in a research report on Friday, August 5th. Finally, Zacks Investment Research raised Syneron Medical from a “sell” rating to a “hold” rating in a research report on Monday, July 25th.

The company’s market capitalization is $231.40 million. The firm has a 50 day moving average price of $7.00 and a 200-day moving average price of $7.16.

Syneron Medical (NASDAQ:ELOS) last released its quarterly earnings data on Thursday, August 4th. The company reported $0.09 EPS for the quarter, beating the consensus estimate of $0.06 by $0.03. During the same period last year, the business earned $0.07 earnings per share. The company earned $75 million during the quarter, compared to analysts’ expectations of $75.72 million. The company’s revenue for the quarter was up 2.0% compared to the same quarter last year. Equities analysts predict that Syneron Medical Ltd. will post $0.27 earnings per share for the current fiscal year.

Syneron Medical Ltd. is engaged in the manufacture, research, development, marketing and sale of equipment for the aesthetic medical industry and systems for dermatologists, plastic surgeons and other qualified practitioners. The Company designs, develops and markets aesthetic medical products based on its various technologies, including Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy to provide aesthetic medical treatments.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.